Alvotech

NASDAQ:ALVO

Drug Manufacturers - Specialty & Generic

Healthcare
$4.55 -1.02%

-$0.04 today

Market cap
$1.62B
Beta
0.21
P/E (TTM)
-15.9
EPS (TTM)
-$0.24
52W Low $2.94High $9.94

Volume 1.56M

Average 0.65M

ALVO Pre-Tax Margin

Income before tax as a percentage of revenue.

AlvotechNASDAQ: ALVO

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin narrows to 0.9%

Pre-tax margin was 0.9% in Q1 FY2026, down 69.4 pp from a year earlier. On a trailing-twelve-month basis it was 7.8%, down 9.4 pp year over year. Over 3 fiscal years it widened by 687.7 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
0.9%-22.9 pp QoQ
Last fiscal yearDec 2025
23.3%+67.7 pp YoY
LTMMar 2026
7.8%-9.4 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-69.4 pp——
1 year+67.7 pp——
3 years+687.7 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
23.3%
Year-over-year change
+67.7pp

Pre-Tax Margin vs competitors

How ALVO compares with its peers on the latest reported figures

  • ALVO's LTM Mar 2026 pre-tax margin of 7.8% is the 7th highest of the 11 companies compared; the peer median is 8.4%.
  • Its year-over-year change of -9.4 pp is the 10th highest of 11, against a peer median of +3.6 pp.
  • Over three fiscal years its change of +687.7 pp compares with a peer median of +5.9 pp.
ALVO Competitors Peer median
Pre-Tax Margin for ALVO and competitors
Company Period LTM level YoY 3-year change
REGNRegeneron Pharmaceuticals, Inc.LTM Jun 202633.3% -1.0 pp-3.4 pp
AMGNAmgen Inc.LTM Jun 202627.0% +5.7 pp-3.5 pp
AMPHAmphastar Pharmaceuticals, Inc.LTM Mar 202614.3% -9.5 pp-5.8 pp
COLLCollegium Pharmaceutical, Inc.LTM Mar 202613.6% +3.8 pp+18.1 pp
BIIBBiogen Inc.LTM Jun 20268.6% -9.4 pp-21.0 pp
OGNOrganon & Co.LTM Sep 20268.2% -2.9 pp-11.3 pp
ALVOAlvotechLTM Mar 20267.8% -9.4 pp+687.7 pp
AMRXAmneal Pharmaceuticals, Inc.LTM Jun 20266.5% +3.3 pp+15.8 pp
TEVATeva Pharmaceutical Industries LimitedLTM Jun 20264.2% +4.6 pp+28.2 pp
ETONEton Pharmaceuticals, Inc.LTM Mar 2026-1.7% +7.6 pp+36.7 pp
HROWHarrow Health, Inc.LTM Mar 2026-4.2% +6.0 pp+15.2 pp
Peer median (excluding ALVO) 8.4%+3.6 pp+5.9 pp

Competitors are the stored peer set for ALVO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue36.77M83.03M91.43M489.68M586.32M
Cost of Revenue064.1M160.86M185.31M235.56M
Gross Profit36.77M18.93M(69.42M)304.37M350.76M
Gross Margin100.0%22.8%-75.9%62.2%59.8%
Research & Development191.01M180.62M210.83M171.31M184.19M
Selling, General & Admin84.13M186.74M73.04M61.45M90.95M
Operating Expenses272.23M365.38M285.44M234.73M272.56M
Depreciation & Amortization18.2M20.41M24.21M31.3M37.85M
EBITDA(18.03M)(439.8M)(493.67M)(32.28M)323.39M
EBITDA Margin-49.0%-529.7%-539.9%-6.6%55.2%
Operating Income(235.46M)(346.44M)(354.86M)69.64M78.21M
Operating Margin-640.3%-417.3%-388.1%14.2%13.3%
Interest Income19K912K4.82M4.62M198.49M
Interest Expense112.97M91.44M134.82M157.6M149.19M
Other Income / Expenses86.26M(205.21M)(296.19M)(287.21M)58.14M
Income Before Tax(149.2M)(551.65M)(651.05M)(217.56M)136.35M
Pre-Tax Margin-405.7%-664.4%-712.0%-44.4%23.3%
Income Tax Expense(47.69M)(38.07M)(99.32M)14.3M108.43M
Net Income(101.5M)(513.58M)(551.73M)(231.86M)27.92M
Net Margin-276.0%-618.6%-603.4%-47.3%4.8%
EPS (Basic)(3.25)(2.60)(2.43)(0.87)0.10
EPS (Diluted)(3.25)(2.60)(2.43)(0.87)0.10
Weighted Avg Shares31.25M197.72M227.26M267.92M279.19M
Weighted Avg Shares (Diluted)31.25M197.72M227.26M267.92M279.19M

Alvotech

NASDAQ:ALVO

Intrinsic Alpha fair value

Locked

Current Price

$4.55

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.